News: Geron Corp (GERN.OQ)

GERN.OQ on NASDAQ Stock Exchange Global Select Market

3.06USD
24 Dec 2014
Price Change (% chg)

-- (--)
Prev Close
$3.06
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
1,161,612
52-wk High
$5.58
52-wk Low
$1.31

Search Stocks
Select another date:

Fri, Nov 14 2014

US STOCKS-Wall St flat after retail sales, UMich data

* Indexes: Dow off 0.01 pct, S&P up 0.05 pct, Nasdaq up 0.07 pct (Adds UMich data, Virgin America IPO)

US STOCKS-Wall St opens flat after retail sales, UMich data on tap

* Indexes: Dow off 0.04 pct, S&P flat, Nasdaq off 0.11 pct (Updates to market open)

US STOCKS-Wall St to open flat after retail sales, UMich data due

* Futures up: Dow 7 pts, S&P 0.5 pt, Nasdaq 0.75 pt (Adds data, updates prices)

US STOCKS-Futures flat ahead of retail sales, UMich data

* Futures up: Dow 11 pts, S&P 1.5 pt, Nasdaq 2.75 pts (Adds premarket actives)

US STOCKS-Futures little changed ahead of data

NEW YORK, Nov 14 - U.S. stock index futures were little changed on Friday, with the S&P on track for a fourth straight weekly advance, ahead of data on consumer sentiment.

Geron sells last drug in pipeline to J&J unit

- Geron Corp licensed its cancer compound, the last in its pipeline, to a unit of Johnson & Johnson for up to $935 million, sending its shares up as much as 33 percent in extended trading.

Geron sells last drug in pipeline to J&J unit

Nov 13 - Geron Corp licensed its cancer compound, the last in its pipeline, to a unit of Johnson & Johnson for up to $935 million, sending its shares up as much as 33 percent in extended trading.

Select another date:
Search Stocks